COMMUNIQUÉS West-GlobeNewswire

Immuron Announces A$5.1M Private Placement to U.S. Fund
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
13/03/2018
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]
CORRECTING and REPLACING -- Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) please note that the conference date should be March 20, not [...]
Antares Pharma Provides Update Regarding the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
EWING, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that due to the blizzard conditions and lack of travel options present in the greater Boston area, the [...]
Xeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei Pharma
13/03/2018
Chicago, March 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Vericel to Present at the 17th Annual Needham Healthcare Conference
13/03/2018
CAMBRIDGE, Mass., March 13, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Sienna Senior Living Inc. Added to S&P/TSX Composite Index
13/03/2018
MARKHAM, Ontario, March 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) is pleased to announce that it will be added to the S&P/TSX Composite Index effective March [...]
Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors
13/03/2018
Lisa Colleran and Benjamin Wolin Unanimously Appointed to Rockwell Board Wolin Named Chairman of the Board Company Reaches Support Agreement with Richmond Brothers WIXOM, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- [...]
Melinta Therapeutics Cancels Presentation at The Cowen & Company 38th Annual Health Care Conference Due to Inclement Weather
13/03/2018
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]
ERYTECH to Webcast Presentation at the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
ERYTECH to Webcast Presentation at the Cowen and Company 38 th Annual Healthcare Conference Lyon (France), March 13, 2018 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical [...]
Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018
13/03/2018
JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]
Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018
13/03/2018
BUENA, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 28 th Annual Healthcare Conference. The [...]
Auris Medical Provides Business Update
13/03/2018
Zug, Switzerland, March 13, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today provided an [...]
SELLAS Life Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Coherus BioSciences Announces New Employment Inducement Grants
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that effective March 12, 2018, the compensation committee of the company’s board of directors granted 2 [...]
Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer
13/03/2018
BURNABY, British Columbia, March 13, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical stage biopharmaceutical company, today announced that Dr. Ernesto Aycardi will join the company as its [...]
MediWound to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call on March 19 at 8:30 a.m. Eastern Time
13/03/2018
YAVNE, Israel, March 13, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Immunovaccine to Host Investor Event on April 10, 2018 in New York City
13/03/2018
HALIFAX, Nova Scotia, March 13, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will host an R&D Update and Investor Event for [...]

Pages